Overview

Global demographics will continue to favor the healthcare and medical device markets for the foreseeable future. Material and equipment technology development continues to support clinical advancements. Continued digitization and integration of machine and patient data will drive improved patient care and operational efficiency. Go to market channels will continue to evolve as new generations of care providers gain influence over buying decisions and methodologies. New companies will continue to develop as clinicians and technologists collaborate on new approaches. Technology and clinical platforms will continue to advance globally as markets efficiently adopt best practice.

Our Capabilities

Vibrant product development & life cycle management
Effective global commercialization (field, telephonic, e-commerce, distribution)
Successful M&A - identification, negotiation, integration, leveraging
Price optimization
Restructuring & remediation

Our Experience

Highly experienced in a variety of medical device segments. Fifteen years in FDA regulated global medical device (materials & equipment) design, manufacturing, sales and distribution provides unique in depth perspective to support a wide range of healthcare/medical device/pharma segments.

For additional insight, please explore CASE STUDIES below.

CASE STUDIES

Complex Restructuring$3B public medical device companyConsumable materials & capital equipmentGlobal — ***Complex Restructuring***
$3B public medical device company
Consumable materials & capital equipment
Global

Interim Leadership$4B public medical device companyConsumable materials & capital equipmentGlobal — ***Interim Leadership***
$4B public medical device company
Consumable materials & capital equipment
Global

Accelerating Product DevelopmentMultiple $100M+ subsidiaries of $3B public medical device companyConsumable materials & equipmentUnited States — ***Accelerating Product Development***
Multiple $100M+ subsidiaries of $3B public medical device company
Consumable materials & equipment
United States

Product Portfolio TransformationSub $100M subsidiary of $3B public medical device companyConsumable injection molded devicesUnited States — ***Product Portfolio Transformation***
Sub $100M subsidiary of $3B public medical device company
Consumable injection molded devices
United States

Global e-commerce$3B public medical device companyConsumable materials & equipmentGlobal — ***Global e-commerce***
$3B public medical device company
Consumable materials & equipment
Global

Urgent Business Remediation$700M+ PE backed medical device companyCapital equipmentUnited States & Europe — ***Urgent Business Remediation***
$700M+ PE backed medical device company
Capital equipment
United States & Europe

Acquisition Through PartneringSub $100M private medical device companyConsumable injection molded devicesNew Zealand — ***Acquisition Through Partnering***
Sub $100M private medical device company
Consumable injection molded devices
New Zealand

Multiple Acquisition Integrations3 separate sub $100M founder owned medical device companiesConsumable materials & devicesUnited States, Europe, Asia — ***Multiple Acquisition Integrations***
3 separate sub $100M founder owned medical device companies
Consumable materials & devices
United States, Europe, Asia

Price OptimizationMultiple $100M+ subsidiaries of $3B public medical device companyConsumable materials & equipmentUnited States — ***Price Optimization***
Multiple $100M+ subsidiaries of $3B public medical device company
Consumable materials & equipment
United States

German Rationalization$100M+ subsidiary of $3B public medical device companyConsumable materials & capital equipmentGermany — ***German Rationalization***
$100M+ subsidiary of $3B public medical device company
Consumable materials & capital equipment
Germany

Integrating Sales OrganizationsMultiple $100M+ subsidiaries of $3B public medical device companyConsumable materials & equipmentUnited States — ***Integrating Sales Organizations***
Multiple $100M+ subsidiaries of $3B public medical device company
Consumable materials & equipment
United States

Supply Chain RestructuringSub $100M subsidiary of $3B public medical device companyPharmaceuticalUnited States — ***Supply Chain Restructuring***
Sub $100M subsidiary of $3B public medical device company
Pharmaceutical
United States

Mentoring$300M+ PE backed medical device companyCapital equipmentUnited States, Europe, Middle East — ***Mentoring***
$300M+ PE backed medical device company
Capital equipment
United States, Europe, Middle East